The global Microscope Software Market is expected to be valued at USD 1,490.0 Million by 2028 from USD 568.51 Million in 2020, registering a CAGR of 12.8% through the forecast period. The growing investment in the field of medical technology, the rising usage of microscopy in varied applications, and the advent of technically advanced software solutions are contributing to the market growth. The software helps generate 3D data of the sample and enables the researchers to gather vital information in real-time. This is further projected to drive market growth.
Advances in biomedical and pharmaceutical research have led to the generation of enormous biological data that are bolstering the demand for robust software solutions and advanced microscopy, thereby augmenting the market growth. Moreover, the surging emphasis on R&D across various industrial verticals such as automotive, aerospace, healthcare, and the increasing incorporation of microscopes in industries such as polymers are further predicted to propel the industry’s growth in the timeframe.
However, the dearth of skilled professionals, the high costs of the microscopes and software subscriptions, and the availability of numerous open-source software are projected to bolster the market growth over the estimated timeframe.
Top Companies Profiled in the Report Include: Carl Zeiss AG, Arivis AG, Nikon Corporation, Thermo Fisher Scientific, Inc., Danaher Corporation, Olympus Corporation, Scientific Volume Imaging B.V., Oxford Instruments Plc., Object Research Systems, Inc., Hitachi High-Tech Corporation, and JEOL Ltd., among others.
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.